-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Dianthus Therapeutics, Inc. /DE/ quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2016 to 2024.
- Dianthus Therapeutics, Inc. /DE/ Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$28.4M, a 169% decline year-over-year.
- Dianthus Therapeutics, Inc. /DE/ Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$85M, a 95.1% decline year-over-year.
- Dianthus Therapeutics, Inc. /DE/ annual Net Income (Loss) Attributable to Parent for 2024 was -$85M, a 95.1% decline from 2023.
- Dianthus Therapeutics, Inc. /DE/ annual Net Income (Loss) Attributable to Parent for 2023 was -$43.6M, a 53% decline from 2022.
- Dianthus Therapeutics, Inc. /DE/ annual Net Income (Loss) Attributable to Parent for 2022 was -$28.5M, a 117% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)